BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Sep 9, 2026; 15(3): 120925
Published online Sep 9, 2026. doi: 10.5409/wjcp.120925
Table 1 Clinical timeline: Episodes of acute liver failure
Age
Trigger
Key laboratory findings
Treatment
Outcome
19 monthsFever + URTI; antibiotics and paracetamol givenALT: 1840, AST: 2210, Bili: 340 μmol/L, GGT: 18 (low), INR: 2.8, pancytopeniaCorticosteroids, IV fluids, nutritional supportPartial improvement; no normalisation
21 monthsFebrile illnessALT: 980, AST: 1140, Bili: 210, GGT: 20, INR: 2.1Supportive care; steroids repeatedPartial improvement; ongoing enzyme elevation
22 monthsFebrile UTIALT: 2100, AST: 2450, Bili: 380 μmol/L, INR: 3.1, GGT: 24, Plt: 62Antibiotics + supportive careOngoing follow-up; genetic counselling initiated
Table 2 Laboratory findings across three episodes of acute liver failure
Parameter
Episode 1 (19 months)
Post-Rx (20 months)
Episode 2 (21 months)
Episode 3 (22 months)
Reference
ALT (U/L)184032098021007-45
AST (U/L)22102801140245010-40
Total bilirubin (μmol/L)34095210380< 21
GGT (U/L)18222024< 50
ALP (U/L)95808891< 350
Albumin (g/dL)2.93.43.12.83.5-5.0
INR2.81.62.13.1< 1.2
WBC (× 109/L)2.13.82.42.05-15
Haemoglobin (g/dL)8.29.58.98.011-14
Platelets (× 109/L)681027562150-400
Table 3 Reported cases of SCYL1-associated recurrent acute liver failure and neurological manifestations (literature review)
Ref.
Patient (s)
Genotype
Key phenotypic features
Schmidt et al[8]2 siblings (European), 1 female (Cuban)Compound heterozygous: P.Val313Cysfs*6, p.Ala504Profs*15; p.Gln546*, c.1230+1G>ARALF, chronic fibrosis, CVA, intention tremor, neurogenic stutter
Lenz et al[1]7 pediatric patientsHomozygous nonsense (p.Gln628*, p.Glu86*, p.Gln57*) and missense (p.Asp478Gly, p.Ala105Val)Named CALFAN. Low-GGT cholestasis, RALF; variable neuro-phenotypes
Incecik et al[6]10 years male (Turkish)Homozygous: C.1420C>T (exon 11)First Turkish case; RALF, delayed motor milestones, axonal neuropathy, CVA
Shohet et al[7]28 months male, 18 years aunt (Ashkenazi Jewish)Homozygous synonymous: C.459C>T (exon 4)Aberrant splicing. RALF, short stature, motor neuropathy
Li et al[4]7 years male (Han Chinese)Homozygous frameshift: P.H32Gfs*20 (exon 1)First East Asian case. RALF, late-onset skeletal disease, mild neuro-impairment
Spagnoli et al[9]7 years femaleHomozygous 1-bp duplication: P.Cys512 Leufs*8Predominant neurologic phenotype; recurrent respiratory failure
McNiven et al[10]13 years male, 9 years female (siblings)Compound heterozygous: P.Asn133 Lysfs*136 and multi-exon deletions (exons 7-8)Severe hepatic phenotype requiring liver transplantation; later tremor and cognitive dysfunction
Isa et al[11]5 years male (Bahraini)Homozygous nonsense: C.895A>T (exon 7)RALF triggered by fever, global developmental delay, progressive inability to walk
Zare et al[12]11 years female (Iranian)Homozygous mutation in exon 11Recurrent liver failure, compensated cirrhosis, gait disability, dysarthria, clubfoot
Kazem et al[13]8years female, 9 years male (Kuwaiti Siblings)Homozygous splice site: C.1386+1G>AIntrafamilial variability: Girl had RALF; brother remains asymptomatic
Suenera et al[14]6 years female (Indian)Homozygous frameshift: P.Lys249ArgfsTer58 (exon 6)Overlap with PFIC. Also carried LPAR6 mutation explaining brittle hair
Present case19 months female (Arab)Homozygous nonsense: C.1420C>T (p.Arg474*) (exon 11)RALF × 3, low-GGT cholestasis, pancytopenia, tremors, fine motor delay; partial steroid response


Write to the Help Desk